Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Kangaroo DNA May Provides Insights for Skin Cancer Prevention

By LabMedica International staff writers
Posted on 15 Jan 2010
Understanding how kangaroos repair their DNA could be the key to preventing skin cancer in the future, according to new research.

Dr. More...
Linda Feketeová and Dr. Uta Wille from the ARC Center of Excellence for Free Radical Chemistry and Biotechnology at the University of Melbourne (Australia), together with scientists from the University of Innsbruck (Austria), Dr. Feketeová and Dr. Wille, are working toward reducing the number of skin cancer-related cases by studying the chemistry behind potential skin cancer therapies. The teams are investigating a DNA repair enzyme found in kangaroos and many other organisms, but not humans. This enzyme is very effective in repairing a specific type of DNA damage linked to many skin cancers.

"As summer approaches, excessive exposure to the sun's harmful UV [ultraviolet] light will see more than 400,000 Australians diagnosed with skin cancer,” remarked Dr. Feketeová. "Other research teams have proposed a ‘dream cream' containing the DNA repair enzyme which you could slap on your skin after a day in the sun. We are now examining whether this would be feasible by looking at the chemistry behind the DNA repair system.”

Using highly advanced technology, the groups are simulating the skin's UV exposure in the laboratory, and then analyzing the DNA repair process in a specialized mass spectrometer instrument. "We were quite surprised that the DNA's repair process also resulted in a number of chemical by-products, which have never been seen before,” stated Dr. Wille. "Our plan is to study these products to understand if the DNA repair enzyme could be incorporated into a safe and effective method for skin cancer prevention.”

"But there is still much to investigate before this ‘dream cream' will be available at the pharmacy, so don't throw out your sunscreen just yet,” added Dr. Feketeová.

This work will be published as a "hot paper” in the upcoming edition of the journal Chemical Communications.

Related Links:
ARC Centre of Excellence for Free Radical Chemistry and Biotechnology
University of Innsbruck


New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Human Estradiol Assay
Human Estradiol CLIA Kit
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.